Inspire Medical Systems, Inc. — Form 10-Q
Filed August 3, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Timothy P. Herbert (CEO/Chairperson) and Matthew J. Osberg (CFO) certified the Q2 2026 10-Q for the period ended June 30, 2026, filed August 3, 2026. Both officers attested that financial statements fairly present the company's condition, disclosure controls are effective, and no material weaknesses or fraud involving management were identified in internal controls over financial reporting.
Why this rating
Routine Sarbanes-Oxley officer certifications; standard periodic filing exhibit with no substantive business developments, transactions, or control deficiencies disclosed.
See more from August 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.